Partnership & licensing
The managers of FibroStatin SL would be glad to consider proposals of collaboration and alliance with pharmaceutical and biotechnology companies interested in co-developing therapeutic or diagnostic projects focused on GPBP technology. Moreover, FibroStatin SL is open to establish licensing-out agreements of its patent portfolio and proprietary technology with companies willing to develop projects individually. Inquiries about collaborations and licensing-out should be forwarded to our Scientific Director:
Dr. Juan Saus
fibrostatin@fibrostatin.com
Endogenous GPBP/GPBPΔ26 in HeLa cells
